|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000057608 |
Summary for GDI2 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000057608 | Gene symbol | GDI2 |
| Gene name | GDP dissociation inhibitor 2 | |
| HGNC | 4227 | |
| Entrez ID | 2665 | |
| Gene type | protein_coding | |
| Synonyms | GDI2|RABGDIB | |
| UniProtAcc | P50395 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for GDI2 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for GDI2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for GDI2 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg03626186 | chr10:5840503 | CGI:chr10:5840340-5840672 | promoter,gene body | 6.34e-01 | 7.49e-01 | -2.40e+00 | 1.66e-02 | 3.25e-02 | -1.15e-01 |
| KIRP | cg03626186 | chr10:5840503 | CGI:chr10:5840340-5840672 | promoter,gene body | 3.40e-01 | 2.25e-01 | 4.45e+00 | 8.65e-06 | 8.42e-05 | 1.16e-01 |
| KIRP | cg18184053 | chr10:5840776 | CGI:chr10:5840340-5840672 | promoter,gene body | 6.38e-01 | 4.71e-01 | 5.26e+00 | 1.46e-07 | 1.68e-06 | 1.67e-01 |
| SARC | cg03626186 | chr10:5840503 | CGI:chr10:5840340-5840672 | promoter,gene body | 4.73e-01 | 3.36e-01 | 4.58e+00 | 4.55e-06 | 2.99e-05 | 1.38e-01 |
| SARC | cg13475995 | chr10:5840613 | CGI:chr10:5840340-5840672 | promoter,gene body | 5.32e-01 | 3.82e-01 | 4.06e+00 | 4.97e-05 | 2.76e-04 | 1.50e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg13475995 | chr10:5840613 | CGI:chr10:5840340-5840672 | promoter,gene body | 5.41e-01 | 6.62e-01 | -2.27e+00 | 2.31e-02 | 2.60e-02 | -1.21e-01 |
| BLCA | cg03626186 | chr10:5840503 | CGI:chr10:5840340-5840672 | promoter,gene body | 6.38e-01 | 5.29e-01 | 2.72e+00 | 6.58e-03 | 1.01e-02 | 1.09e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg03626186 | chr10:5840503 | CGI:chr10:5840340-5840672 | promoter,gene body | 6.34e-01 | 4.13e-01 | 1.15e+01 | 8.04e-31 | 1.30e-29 | 2.21e-01 |
| BRCA | cg13475995 | chr10:5840613 | CGI:chr10:5840340-5840672 | promoter,gene body | 5.64e-01 | 2.35e-01 | 1.15e+01 | 7.79e-31 | 1.26e-29 | 3.29e-01 |
| BRCA | cg05572410 | chr10:5840341 | CGI:chr10:5840340-5840672 | promoter,gene body | 4.17e-01 | 2.88e-01 | 7.60e+00 | 2.95e-14 | 1.02e-13 | 1.29e-01 |
| HNSC | cg03626186 | chr10:5840503 | CGI:chr10:5840340-5840672 | promoter,gene body | 4.96e-01 | 6.45e-01 | -2.56e+00 | 1.06e-02 | 1.92e-02 | -1.49e-01 |
| COAD | cg13475995 | chr10:5840613 | CGI:chr10:5840340-5840672 | promoter,gene body | 6.03e-01 | 7.76e-01 | -2.54e+00 | 1.11e-02 | 1.70e-02 | -1.73e-01 |
Top |
Exon skipping events with PSI in TCGA for GDI2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for GDI2 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for GDI2 |
TFs related to GDI2.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| LAML | ZNF25 | GDI2 | 4.43e+00 | 9.81e-01 | 3.50e+00 | 9.07e-03 | Male-biased |
| LAML | ZNF334 | GDI2 | 4.71e+00 | 9.89e-01 | 3.58e+00 | 4.55e-03 | Male-biased |
| LAML | ZNF418 | GDI2 | 5.07e+00 | 9.94e-01 | 3.72e+00 | 1.97e-03 | Male-biased |
| LAML | ZNF79 | GDI2 | 4.61e+00 | 9.87e-01 | 3.53e+00 | 5.31e-03 | Male-biased |
| LAML | ZNF879 | GDI2 | 4.47e+00 | 9.87e-01 | 3.30e+00 | 3.77e-03 | Male-biased |
GDI2 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for GDI2 |
RBPs related to ES in GDI2.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | ANKHD1 | exon_skip_47516 | 1.29e+01 | 1.81e-03 | 1.35e+01 | 9.98e-01 | Female-biased |
| ACC | KHDRBS1 | exon_skip_47516 | 6.58e+00 | 3.35e-03 | 7.12e+00 | 9.83e-01 | Female-biased |
| ACC | MSI1 | exon_skip_47516 | 1.29e+01 | 5.53e-04 | 1.37e+01 | 9.99e-01 | Female-biased |
| ACC | QKI | exon_skip_47516 | 1.11e+01 | 9.77e-04 | 1.18e+01 | 9.98e-01 | Female-biased |
| ACC | SART3 | exon_skip_47522 | 9.09e+00 | 9.81e-01 | 8.71e+00 | 1.42e-02 | Male-biased |
| UVM | ANKHD1 | exon_skip_47516 | 1.16e+01 | 4.62e-04 | 1.21e+01 | 9.99e-01 | Female-biased |
| UVM | KHDRBS3 | exon_skip_47528 | 1.12e+01 | 9.83e-01 | 1.10e+01 | 1.61e-02 | Male-biased |
| UVM | MSI1 | exon_skip_47516 | 1.35e+01 | 3.10e-04 | 1.41e+01 | 9.99e-01 | Female-biased |
| UVM | QKI | exon_skip_47516 | 1.18e+01 | 1.03e-03 | 1.23e+01 | 9.98e-01 | Female-biased |
| THYM | ANKHD1 | exon_skip_47516 | 1.34e+01 | 9.99e-01 | 1.29e+01 | 8.43e-04 | Male-biased |
| THYM | MSI1 | exon_skip_47516 | 1.42e+01 | 9.99e-01 | 1.36e+01 | 7.13e-04 | Male-biased |
| THYM | QKI | exon_skip_47516 | 1.23e+01 | 9.96e-01 | 1.19e+01 | 3.67e-03 | Male-biased |
| LIHC | ANKHD1 | exon_skip_47516 | 1.31e+01 | 4.30e-03 | 1.35e+01 | 9.95e-01 | Female-biased |
| LIHC | MSI1 | exon_skip_47516 | 1.33e+01 | 5.09e-03 | 1.38e+01 | 9.95e-01 | Female-biased |
| LIHC | QKI | exon_skip_47516 | 1.13e+01 | 4.27e-03 | 1.18e+01 | 9.95e-01 | Female-biased |
| LUSC | ESRP2 | exon_skip_47540 | 8.18e+00 | 2.52e-03 | 8.68e+00 | 9.92e-01 | Female-biased |
| COAD | ANKHD1 | exon_skip_47516 | 1.20e+01 | 1.48e-03 | 1.26e+01 | 9.98e-01 | Female-biased |
| COAD | MSI1 | exon_skip_47516 | 1.32e+01 | 6.12e-04 | 1.39e+01 | 9.99e-01 | Female-biased |
| COAD | QKI | exon_skip_47516 | 1.12e+01 | 1.99e-03 | 1.17e+01 | 9.97e-01 | Female-biased |
| DLBC | SART3 | exon_skip_47522 | 8.79e+00 | 9.29e-03 | 9.14e+00 | 9.87e-01 | Female-biased |
| CHOL | ANKHD1 | exon_skip_47516 | 1.29e+01 | 1.40e-03 | 1.36e+01 | 9.98e-01 | Female-biased |
| CHOL | KHDRBS1 | exon_skip_47516 | 6.71e+00 | 5.26e-03 | 7.20e+00 | 9.82e-01 | Female-biased |
| CHOL | KHDRBS3 | exon_skip_47528 | 1.10e+01 | 4.20e-03 | 1.15e+01 | 9.95e-01 | Female-biased |
| CHOL | MSI1 | exon_skip_47516 | 1.36e+01 | 1.30e-03 | 1.43e+01 | 9.99e-01 | Female-biased |
| CHOL | QKI | exon_skip_47516 | 1.17e+01 | 2.69e-03 | 1.23e+01 | 9.97e-01 | Female-biased |
| CHOL | RBM41 | exon_skip_47544 | 1.22e+01 | 9.85e-01 | 1.18e+01 | 1.46e-02 | Male-biased |
| KIRP | ANKHD1 | exon_skip_47516 | 1.25e+01 | 2.21e-03 | 1.29e+01 | 9.97e-01 | Female-biased |
| KIRP | MSI1 | exon_skip_47516 | 1.36e+01 | 6.68e-04 | 1.42e+01 | 9.99e-01 | Female-biased |
| KIRP | QKI | exon_skip_47516 | 1.19e+01 | 2.26e-03 | 1.24e+01 | 9.97e-01 | Female-biased |
| KIRP | SART3 | exon_skip_47522 | 8.70e+00 | 6.51e-03 | 9.07e+00 | 9.89e-01 | Female-biased |
| BRCA | KHDRBS3 | exon_skip_47528 | 1.11e+01 | 9.84e-01 | 1.06e+01 | 1.45e-02 | Male-biased |
| BRCA | MSI1 | exon_skip_47516 | 1.36e+01 | 9.81e-01 | 1.31e+01 | 1.83e-02 | Male-biased |
| ESCA | ANKHD1 | exon_skip_47516 | 1.21e+01 | 7.36e-03 | 1.25e+01 | 9.92e-01 | Female-biased |
| ESCA | MSI1 | exon_skip_47516 | 1.27e+01 | 3.53e-03 | 1.33e+01 | 9.96e-01 | Female-biased |
| ESCA | QKI | exon_skip_47516 | 1.09e+01 | 2.73e-03 | 1.15e+01 | 9.97e-01 | Female-biased |
| READ | ANKHD1 | exon_skip_47516 | 1.22e+01 | 7.64e-04 | 1.28e+01 | 9.99e-01 | Female-biased |
| READ | MSI1 | exon_skip_47516 | 1.35e+01 | 3.64e-04 | 1.41e+01 | 9.99e-01 | Female-biased |
| READ | QKI | exon_skip_47516 | 1.09e+01 | 1.24e-03 | 1.14e+01 | 9.98e-01 | Female-biased |
| PCPG | SART3 | exon_skip_47522 | 9.06e+00 | 9.84e-01 | 8.75e+00 | 1.16e-02 | Male-biased |
| MESO | ANKHD1 | exon_skip_47516 | 1.23e+01 | 9.99e-01 | 1.16e+01 | 5.75e-04 | Male-biased |
| MESO | MSI1 | exon_skip_47516 | 1.38e+01 | 9.99e-01 | 1.32e+01 | 9.68e-04 | Male-biased |
| MESO | QKI | exon_skip_47516 | 1.21e+01 | 9.98e-01 | 1.15e+01 | 1.30e-03 | Male-biased |
| GBM | ANKHD1 | exon_skip_47516 | 1.20e+01 | 1.86e-03 | 1.25e+01 | 9.98e-01 | Female-biased |
| GBM | MSI1 | exon_skip_47516 | 1.29e+01 | 1.09e-03 | 1.35e+01 | 9.99e-01 | Female-biased |
| GBM | QKI | exon_skip_47516 | 1.14e+01 | 2.96e-03 | 1.19e+01 | 9.96e-01 | Female-biased |
| PAAD | KHDRBS3 | exon_skip_47528 | 1.09e+01 | 3.12e-03 | 1.13e+01 | 9.96e-01 | Female-biased |
| KIRC | RBM41 | exon_skip_47544 | 1.14e+01 | 9.84e-01 | 1.11e+01 | 1.47e-02 | Male-biased |
| KIRC | SART3 | exon_skip_47522 | 8.82e+00 | 9.83e-01 | 8.53e+00 | 1.25e-02 | Male-biased |
| KICH | KHDRBS3 | exon_skip_47528 | 1.10e+01 | 9.83e-01 | 1.07e+01 | 1.62e-02 | Male-biased |
| KICH | RBM41 | exon_skip_47544 | 1.14e+01 | 2.45e-03 | 1.18e+01 | 9.97e-01 | Female-biased |
| BLCA | SART3 | exon_skip_47522 | 8.69e+00 | 7.60e-03 | 9.07e+00 | 9.88e-01 | Female-biased |
GDI2 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10508279 | chr10:4258542:C:G | - | -0.173135786652789 | 0.0297588872177099 | GBM | Female-baised eQTL |
| rs74111770 | chr10:4853421:T:C | - | 0.216706380287744 | 0.00702419883632893 | KIRP | Female-baised eQTL |
| rs77529416 | chr10:4853731:T:C | - | 0.216706380287744 | 0.00702419883632893 | KIRP | Female-baised eQTL |
| rs10904021 | chr10:3297513:T:A | - | -0.116255384888689 | 0.00880443960095967 | LIHC | Female-baised eQTL |
| rs4881145 | chr10:3298226:G:A | - | -0.116255384888689 | 0.00880443960095967 | LIHC | Female-baised eQTL |
| rs1886761 | chr10:3299071:C:T | - | -0.116255384888689 | 0.00880443960095967 | LIHC | Female-baised eQTL |
| rs10795022 | chr10:3302782:C:T | - | -0.115135002865729 | 0.0124496492029865 | LIHC | Female-baised eQTL |
| rs548827 | chr10:3305856:C:T | - | 0.115135002865729 | 0.0124496492029865 | LIHC | Female-baised eQTL |
| rs528650 | chr10:3305872:G:A | - | 0.115135002865729 | 0.0124496492029865 | LIHC | Female-baised eQTL |
| rs562636 | chr10:3307300:A:G | - | 0.115135002865729 | 0.0124496492029865 | LIHC | Female-baised eQTL |
| rs1998768 | chr10:3296869:C:T | - | -0.101543594308609 | 0.0419495731793004 | LIHC | Female-baised eQTL |
| rs4881148 | chr10:3300949:C:T | - | -0.103372298794859 | 0.0443111772172129 | LIHC | Female-baised eQTL |
| rs4881149 | chr10:3301856:T:C | - | -0.103372298794859 | 0.0443111772172129 | LIHC | Female-baised eQTL |
| rs4881150 | chr10:3301962:G:T | - | -0.103372298794859 | 0.0443111772172129 | LIHC | Female-baised eQTL |
| rs11598692 | chr10:11375102:G:A | - | 0.0605662374566773 | 0.00214470592845697 | LUAD | Female-baised eQTL |
| rs7087845 | chr10:11373665:C:G | - | 0.0586438880728764 | 0.00254858009399366 | LUAD | Female-baised eQTL |
| rs11595366 | chr10:11372816:A:G | - | 0.0568428842949684 | 0.00338291177586022 | LUAD | Female-baised eQTL |
| rs11257069 | chr10:11370054:A:G | - | 0.0560747279260347 | 0.00598874545986179 | LUAD | Female-baised eQTL |
| rs11591948 | chr10:11370787:C:T | - | 0.0560747279260347 | 0.00598874545986179 | LUAD | Female-baised eQTL |
| rs12722553 | chr10:6029321:C:A | - | 0.05346063806583 | 0.0107978264832656 | LUAD | Female-baised eQTL |
| rs74449098 | chr10:11364361:C:G | - | 0.0536033708643976 | 0.0125457262961582 | LUAD | Female-baised eQTL |
| rs60843666 | chr10:11360291:C:T | - | 0.0518125470480812 | 0.0191885627765361 | LUAD | Female-baised eQTL |
| rs12260396 | chr10:14459448:A:C | - | 0.0781283362869068 | 0.0307731016228785 | LUAD | Female-baised eQTL |
| rs11259118 | chr10:14465884:A:C | - | 0.076742104723088 | 0.0367920661359094 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4564222 | chr10:4879013:C:A | - | -0.064963289907093 | 0.0257602124196244 | LGG | Male-baised eQTL |
| rs56375548 | chr10:4870386:A:C | - | 0.0860987097462829 | 0.0262368243720476 | LGG | Male-baised eQTL |
| rs4460716 | chr10:4877449:G:T | - | -0.0646552525816937 | 0.0272981046410248 | LGG | Male-baised eQTL |
| rs4406725 | chr10:4884074:A:C | - | -0.06329031204788 | 0.0330666072972641 | LGG | Male-baised eQTL |
| rs7922213 | chr10:4881353:C:T | - | -0.0632890831102482 | 0.0357506331414461 | LGG | Male-baised eQTL |
| rs7071257 | chr10:4883816:T:C | - | -0.0631731222741254 | 0.0376761047874638 | LGG | Male-baised eQTL |
| rs4545440 | chr10:4877653:G:A | - | -0.0627551587641142 | 0.0406675953267902 | LGG | Male-baised eQTL |
| rs7911334 | chr10:7315430:A:G | - | -0.0631824279755339 | 0.0471425376451772 | LGG | Male-baised eQTL |
| rs4503432 | chr10:4944278:A:G | - | 0.0511062651078494 | 0.0018189762133194 | KIRC | Male-baised eQTL |
| rs11818544 | chr10:4945654:C:G | - | 0.0505604914381021 | 0.00188596174586257 | KIRC | Male-baised eQTL |
| rs75404502 | chr10:5589439:C:G | - | 0.0447132680608863 | 0.00600702509013943 | KIRC | Male-baised eQTL |
| rs11597133 | chr10:5589810:A:G | - | 0.0447132680608863 | 0.00600702509013943 | KIRC | Male-baised eQTL |
| rs11599233 | chr10:5589880:G:A | - | 0.0447132680608863 | 0.00600702509013943 | KIRC | Male-baised eQTL |
| rs11597591 | chr10:5590146:A:G | - | 0.0447132680608863 | 0.00600702509013943 | KIRC | Male-baised eQTL |
| rs76074975 | chr10:5590432:G:C | - | 0.0447132680608863 | 0.00600702509013943 | KIRC | Male-baised eQTL |
| rs10905404 | chr10:8547916:T:C | - | 0.037226843339026 | 0.00632563970124358 | KIRC | Male-baised eQTL |
| rs117114269 | chr10:5590587:A:G | - | 0.0445490937537788 | 0.00642096214809705 | KIRC | Male-baised eQTL |
| rs71481745 | chr10:7867034:G:A | - | 0.0496042598102625 | 0.00698964215372652 | KIRC | Male-baised eQTL |
| rs61729619 | chr10:5277201:G:A | - | 0.0538388940120312 | 0.00759832120700977 | KIRC | Male-baised eQTL |
| rs61832638 | chr10:5529250:C:T | - | 0.0294607264615664 | 0.00809661747747716 | KIRC | Male-baised eQTL |
| rs78695884 | chr10:5262846:G:A | - | 0.0534971326407104 | 0.00839739119254782 | KIRC | Male-baised eQTL |
| rs74842916 | chr10:5228996:A:C | - | 0.0518850076628006 | 0.011128850604711 | KIRC | Male-baised eQTL |
| rs12778232 | chr10:7988126:T:C | - | 0.0450685696583282 | 0.0135158617294495 | KIRC | Male-baised eQTL |
| rs7097012 | chr10:8538364:T:C | - | -0.0354836987910065 | 0.0137001272268824 | KIRC | Male-baised eQTL |
| rs7074865 | chr10:8538365:G:A | - | -0.0354836987910065 | 0.0137001272268824 | KIRC | Male-baised eQTL |
| rs66728220 | chr10:5529039:C:T | - | 0.0293604945969953 | 0.0139676081067535 | KIRC | Male-baised eQTL |
| rs4077511 | chr10:5536209:G:A | - | 0.0306900417956313 | 0.0151234630294466 | KIRC | Male-baised eQTL |
| rs1325886 | chr10:8555569:T:G | - | 0.0344588255010802 | 0.0183342908546617 | KIRC | Male-baised eQTL |
| rs35867629 | chr10:5021297:G:A | - | 0.0414101679853007 | 0.0206337443170139 | KIRC | Male-baised eQTL |
| rs77068362 | chr10:7999435:A:G | - | 0.0431429680414835 | 0.0217892186799954 | KIRC | Male-baised eQTL |
| rs7083651 | chr10:7999512:A:G | - | 0.0426168399764991 | 0.0230462614690102 | KIRC | Male-baised eQTL |
| rs35135595 | chr10:8004979:A:C | - | 0.0426168399764991 | 0.0230462614690102 | KIRC | Male-baised eQTL |
| rs12778847 | chr10:8007808:A:G | - | 0.0426168399764991 | 0.0230462614690102 | KIRC | Male-baised eQTL |
| rs80291388 | chr10:13756784:G:A | - | 0.0402666404561166 | 0.0313605887035866 | KIRC | Male-baised eQTL |
| rs75312017 | chr10:13756912:G:A | - | 0.0402666404561166 | 0.0313605887035866 | KIRC | Male-baised eQTL |
| rs10905407 | chr10:8552949:A:T | - | -0.0325578645222593 | 0.0320374242044559 | KIRC | Male-baised eQTL |
| rs7097313 | chr10:8530688:C:T | - | 0.0326590539109384 | 0.0320414644244146 | KIRC | Male-baised eQTL |
| rs11255734 | chr10:8532111:G:T | - | 0.0310617495267242 | 0.0332233185308477 | KIRC | Male-baised eQTL |
| rs34502665 | chr10:7970729:A:T | - | 0.0423175559665872 | 0.0348399811011536 | KIRC | Male-baised eQTL |
| rs7096633 | chr10:7976144:G:A | - | 0.0423175559665872 | 0.0348399811011536 | KIRC | Male-baised eQTL |
| rs34704750 | chr10:7969355:T:C | - | 0.0422556891430293 | 0.0353210958442744 | KIRC | Male-baised eQTL |
| rs79846128 | chr10:5275582:A:T | - | 0.0403975469008332 | 0.0358668934512503 | KIRC | Male-baised eQTL |
| rs2151018 | chr10:7876009:C:T | - | -0.0370183485405825 | 0.037108482013683 | KIRC | Male-baised eQTL |
| rs2646394 | chr10:8534634:A:G | - | 0.0319334132210323 | 0.0408161773890217 | KIRC | Male-baised eQTL |
| rs2646393 | chr10:8534666:G:T | - | 0.031748767336965 | 0.0435860394773066 | KIRC | Male-baised eQTL |
| rs2765404 | chr10:8536485:T:G | - | 0.0318728999150547 | 0.0436043885924983 | KIRC | Male-baised eQTL |
| rs2477922 | chr10:8528309:T:G | - | 0.0313518496721212 | 0.045189050724 | KIRC | Male-baised eQTL |
| rs71481749 | chr10:7943455:G:A | - | 0.0375195173092309 | 0.045370504315529 | KIRC | Male-baised eQTL |
| rs2477920 | chr10:8528759:G:A | - | 0.0312868311874555 | 0.0455322266526284 | KIRC | Male-baised eQTL |
| rs12763771 | chr10:7947397:A:C | - | 0.0373295032041752 | 0.0478844831946684 | KIRC | Male-baised eQTL |
| rs2789622 | chr10:8176066:C:T | - | 0.0429826339419282 | 0.00662791957749039 | BLCA | Male-baised eQTL |
| rs565371 | chr10:8176106:A:C | - | 0.0429826339419282 | 0.00662791957749039 | BLCA | Male-baised eQTL |
| rs10795855 | chr10:11271181:G:A | - | 0.0410367656229374 | 0.0167763149035855 | BLCA | Male-baised eQTL |
| rs7074902 | chr10:8355475:G:T | - | 0.0383913319469502 | 0.0410149221320783 | BLCA | Male-baised eQTL |
| rs7097126 | chr10:8354885:C:G | - | 0.038181949155766 | 0.0417932314261003 | BLCA | Male-baised eQTL |
| rs17303442 | chr10:15710059:A:C | - | 0.0800530805398145 | 0.0211741818127669 | COAD | Male-baised eQTL |
| rs139201360 | chr10:15692891:A:G | - | 0.0785864966393973 | 0.0246819694915662 | COAD | Male-baised eQTL |
| rs78349890 | chr10:15713828:A:G | - | 0.0737911694470413 | 0.0377116909545016 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Gene ID: ENSG00000057608 | |
| CpG Site: cg27407423 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.342966395589422 |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg27407423 | chr10:5809637 | gene | -0.342966395589422 | 5.87124031256736e-05 | -0.5929457239232265 | 3.252294344259945e-08 | KIRP |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of GDI2 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000057608 | GDI2 | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |